4
Changes in Ownership
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Filed Acc 0001127602-22-006657
EVP, Corp Strategy & Develop sold 395 shares at $292.75 ($115,636)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| LaPlume Joseph W EVP, Corp Strategy & Develop | 2022-02-23 | Sale | −395 | $292.75 | $115,636 | 19,852 | D |
| Open-market sales · 395 sh · avg $292.75 · $115,636 | |||||||
Loading xslF345X03/form4.xml…